Cytokinetics Inc (CYTK)
US$ 313.8%
Price Chart
Key Statistics
Market Cap
$ 3.56B
P/E Ratio
0.00
Revenue (TTM)
$ 19.22M
Volume
1.99M
52W High
$ 61.40
52W Low
$ 29.31
Dividend Yield
0.00%
Beta
0.81
Technicals
50-Day MA
39.5204
200-Day MA
48.5284
52 Week High
61.4
52 Week Low
29.31
About CYTK
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di.
Employees
498
Headquarters
South San Francisco, CA
CEO
Mr. Robert I. Blum
Latest News
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
7 hours ago • Google News
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Ru - GuruFocus
7 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg